Guideline to regulations for radiopharmaceuticals in early phase clinical trials in the EU.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 18690437.
- Also identified by DOI 10.1007/s00259-008-0853-7.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this guideline is to help investigators by giving an overview of relevant current EU requirements concerning the quality of starting materials and final drug products (the radiopharmaceuticals), the non-clinical safety studies and dosimetry considerations whilst designing a human clinical trial which includes the use of radiopharmaceutical compounds.
Medical subject headings
- Clinical Trials as Topic
- Radiopharmaceuticals